GWS
BSX icon

Greykasell Wealth Strategies’s Boston Scientific BSX Stock Holding History

Greykasell Wealth Strategies’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.2K Sell
1,175
-557
-32% -$30.2K 0.02% 231
2026
Q1 		$109K Sell
1,732
-127
-7% -$10.2K 0.04% 185
2025
Q4 		$177K Buy
1,859
+271
+17% +$26.6K 0.07% 152
2025
Q3 		$155K Hold
1,588
– – 0.07% 151
2025
Q2 		$171K Hold
1,588
– – 0.08% 136
2025
Q1 		$160K Buy
+1,588
New +$160K 0.09% 130

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Greykasell Wealth Strategies's BSX Position: Q2 2026 in Review

Greykasell Wealth Strategies reduced its Boston Scientific (BSX) stake by 32% in Q2 2026, selling an estimated $30.2K and leaving 1,175 shares worth $50.2K. The position accounts for 0.02% of the portfolio, ranked #231.

Greykasell Wealth Strategies first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $177K in Q4 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Greykasell Wealth Strategies held 1,175 shares of Boston Scientific worth $50.2K as of Q2 2026.
  • Greykasell Wealth Strategies sold 557 Boston Scientific shares in Q2 2026, an estimated $30.2K.
  • Boston Scientific made up 0.02% of Greykasell Wealth Strategies's portfolio in Q2 2026, its #231 holding.
  • Greykasell Wealth Strategies first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
  • Greykasell Wealth Strategies's Boston Scientific position peaked at $177K in Q4 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Greykasell Wealth Strategies's 13F filing for Q2 2026, filed 11 Aug 2026.